Kwangdong’s U to emerge as lead market
Published: 2008-09-04 06:55:00
Updated: 2008-09-04 06:55:00
Kwangdong Pharm’s Uwhangchungsimwon (UC) is likely to regain its momentum as the market’s leading player Chosun Pharm is unable to release its products due to in-house problems, according to pharmaceutical business sources.
UC has been known to have a preventive effect on ischemia-induced brai...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
